SK Innovation Co., Ltd.:企業の戦略・SWOT・財務情報

◆英語タイトル:SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4319
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥45,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥68,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

SK Innovation Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

SK Innovation Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

SK Innovation Co. Ltd. (SK Innovation or ‘the company’) is engaged in the manufacturing and sale of petroleum, petrochemical, and lubricant products. The company is also involved in the alternative energy business as well as oil exploration and production activities. It has exploration and production activities in oil and gas blocks as well as liquefied natural gas (LNG) projects. SK Innovation is headquartered in Seoul, South Korea.

Scope

- Detailed information on SK Innovation Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting SK Innovation Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of SK Innovation Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on SK Innovation Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about SK Innovation Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of SK Innovation Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess SK Innovation Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on SK Innovation Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
SK Innovation Co., Ltd.: Company Overview 9
SK Innovation Co., Ltd.: Overview and Key Facts 9
SK Innovation Co., Ltd.: Overview 9
SK Innovation Co., Ltd.: Key Facts 9
SK Innovation Co., Ltd.: Key Employees 11
SK Innovation Co., Ltd.: Key Employee Biographies 12
SK Innovation Co., Ltd.: Major Products and Services 14
SK Innovation Co., Ltd.: Company History 15
SK Innovation Co., Ltd.: Management Statement 22
SK Innovation Co., Ltd.: Locations and Subsidiaries 23
SK Innovation Co., Ltd.: Key Competitors 24
SK Innovation Co., Ltd.: Company Analysis 25
SK Innovation Co., Ltd.: Business Description 25
SK Innovation Co., Ltd.: SWOT Analysis 27
SK Innovation Co., Ltd.: SWOT Overview 27
SK Innovation Co., Ltd.: Strengths 27
SK Innovation Co., Ltd.: Weaknesses 27
SK Innovation Co., Ltd.: Opportunities 28
SK Innovation Co., Ltd.: Threats 28
SK Innovation Co., Ltd.: Corporate Financial Deals Activity 30
SK Innovation Co., Ltd.: Financial Deals Overview 30
SK Innovation Co., Ltd.: Top Deals 2014 – 2018YTD* 32
SK Innovation Co., Ltd.: Advisors 33
SK Innovation Co., Ltd.: Top Financial Advisors 33
SK Innovation Co., Ltd.: Capital Raising 34
SK Innovation Co., Ltd.: Divestments 35
SK Innovation Co., Ltd.: Recent Developments 36
SK Innovation Co., Ltd.: News and Events Summary 36
SK Innovation Co., Ltd.: Financial Performance 39
SK Innovation Co., Ltd.: Regulatory and Legal Events 39
SK Innovation Co., Ltd.: Strategy and Operations 40
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: SK Innovation Co., Ltd.: Key Facts
Table 2: SK Innovation Co., Ltd.: Key Employees
Table 3: SK Innovation Co., Ltd.: Locations and Subsidiaries
Table 4: SK Innovation Co., Ltd.: Key Competitors
Table 5: SK Innovation Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: SK Innovation Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: SK Innovation Co., Ltd.: Top Deals 2014 - 2018YTD*
Table 8: SK Innovation Co., Ltd.: Financial Advisor Ranking by Value (US$m)
Table 9: SK Innovation Co., Ltd.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 10: SK Innovation Co., Ltd.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 11: SK Innovation Co., Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 12: SK Innovation Co., Ltd.: Divestments by Geography (2014 - YTD*2018)
Table 13: SK Innovation Co., Ltd.: News and Events Summary
Table 14: SK Innovation Co., Ltd.: Financial Performance
Table 15: SK Innovation Co., Ltd.: Regulatory and Legal Events
Table 16: SK Innovation Co., Ltd.: Strategy and Operations

List of Figures
Figure 1: SK Innovation Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: SK Innovation Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: SK Innovation Co., Ltd.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: SK Innovation Co., Ltd.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: SK Innovation Co., Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: SK Innovation Co., Ltd.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[SK Innovation Co., Ltd.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Zosen Corporation (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corporation (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Eurobio Scientific SA (ALEHT):医療機器:M&Aディール及び事業提携情報
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, which is used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic i …
  • Lanco Infratech Ltd (LITL):企業の財務・戦略的SWOT分析
    Lanco Infratech Ltd (LITL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Punjab & Sind Bank:企業の戦略・SWOT・財務情報
    Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Peco Energy Company:電力:M&Aディール及び事業提携情報
    Summary PECO Energy Company (PECO), a subsidiary of Exelon Corporation, is a public utility that purchases and sells electricity and gas, and provides electricity transmission and distribution, and gas distribution services. It supplies electricity and gas to residential, commercial, and industrial …
  • DiamondRock Hospitality Co:企業のM&A・事業提携・投資動向
    DiamondRock Hospitality Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DiamondRock Hospitality Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Viridian Group Investments Limited:戦略・SWOT・企業財務分析
    Viridian Group Investments Limited - Strategy, SWOT and Corporate Finance Report Summary Viridian Group Investments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Theralase Technologies Inc (TLT):企業の財務・戦略的SWOT分析
    Summary Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical applications. The company is focused on the development …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • USV Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary USV Pvt Ltd (USV) is a healthcare company that offers pharmaceutical products. The company’s products include active pharmaceutical ingredients, biosimilars, injectables, ophthalmics, peptides and solid orals. Its biosimilars products comprise PEG-filgrastim, teriparatide, somatropin, filgra …
  • Rohto Pharmaceutical Co Ltd (4527):製薬・医療:M&Aディール及び事業提携情報
    Summary Rohto Pharmaceutical Co Ltd (Rohto Pharmaceutical) is a pharmaceutical company that manufactures and markets cosmetics and functional foods. The company offers products such as eye care products, skin care products, oral medicine product, cosmetics, eye drops, gastrointestinal medicines, der …
  • Entasis Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Entasis Therapeutics Inc (Entasis) discovers and develops anti-infective products for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, a potent inhibitor of class A, C, and D beta-lactamases intended to treat serious gram-negative infections, such as Acin …
  • A. H. Belo Corporation:企業のM&A・事業提携・投資動向
    A. H. Belo Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's A. H. Belo Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Jindal Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Jindal Power Ltd (JPL) a subsidiary of Jindal Steel & Power Ltd, is a power generation company that builds and operates power plants. The company offers implementation, operation and planning of thermal power, hydroelectric and renewable energy power plants. Its hydroelectric projects includ …
  • Royal DSM N.V.:企業のM&A・事業提携・投資動向
    Royal DSM N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal DSM N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Lee Memorial Health System:企業の戦略的SWOT分析
    Lee Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hewlett Packard Enterprise Company:企業の戦略・SWOT・財務分析
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep T …
  • Renova Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Renova Therapeutics Inc (Renova) is a drug development company that focuses on the development of peptide infusion therapies and gene therapy treatments for cardiovascular and metabolic diseases. The company’s pipeline products include RT-100, RT-200, RT-110, RT-400, RT-210 and RT-300. Its R …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆